CB
CBD of Denver, Inc.
CBDD · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $1.07M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
0/9Valuation
33 /100
Expensive EV/EBITDA 24.66x
P/S 0.29x
P/E N/A
Growth
0 /100
Declining Rev. growth 45.23%
EPS growth N/A
FCF growth N/A
Profitability
2 /100
Weak Gross margin 5.81%
Net margin 2.13%
Op. margin 1.98%
Quality
21 /100
Poor ROIC 27.67%
ROA 196.09%
Asset turnover 92.10x
Debt
2 /100
High Current ratio 0.03x
Int. coverage 0.49x
Net debt/EBITDA 12.06x
Stability
19 /100
Unstable Beta -8.68x
Rev. volatility 67.15%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CBDD
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Jan Schwager
Employees
2
Headquarters
Centennial